0001371128 false Q2 --12-31 0001371128 2022-01-01 2022-06-30 0001371128 2022-08-09 0001371128 2022-06-30 0001371128 2021-12-31 0001371128 2022-04-01 2022-06-30 0001371128 2021-04-01 2021-06-30 0001371128 2021-01-01 2021-06-30 0001371128 us-gaap:PreferredStockMember 2020-12-31 0001371128 NEWH:MezzanineMember 2020-12-31 0001371128 us-gaap:CommonStockMember 2020-12-31 0001371128 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001371128 us-gaap:RetainedEarningsMember 2020-12-31 0001371128 2020-12-31 0001371128 us-gaap:PreferredStockMember 2021-12-31 0001371128 NEWH:MezzanineMember 2021-12-31 0001371128 us-gaap:CommonStockMember 2021-12-31 0001371128 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001371128 us-gaap:RetainedEarningsMember 2021-12-31 0001371128 us-gaap:PreferredStockMember 2021-01-01 2021-06-30 0001371128 NEWH:MezzanineMember 2021-01-01 2021-06-30 0001371128 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001371128 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001371128 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001371128 us-gaap:PreferredStockMember 2022-01-01 2022-06-30 0001371128 NEWH:MezzanineMember 2022-01-01 2022-06-30 0001371128 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001371128 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001371128 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001371128 us-gaap:PreferredStockMember 2021-06-30 0001371128 NEWH:MezzanineMember 2021-06-30 0001371128 us-gaap:CommonStockMember 2021-06-30 0001371128 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001371128 us-gaap:RetainedEarningsMember 2021-06-30 0001371128 2021-06-30 0001371128 us-gaap:PreferredStockMember 2022-06-30 0001371128 NEWH:MezzanineMember 2022-06-30 0001371128 us-gaap:CommonStockMember 2022-06-30 0001371128 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001371128 us-gaap:RetainedEarningsMember 2022-06-30 0001371128 2021-01-01 2021-12-31 0001371128 NEWH:EmployeeMember 2015-03-23 2015-03-24 0001371128 srt:DirectorMember 2015-08-30 2015-09-02 0001371128 2022-03-24 0001371128 srt:DirectorMember 2015-09-02 0001371128 NEWH:EmployeeMember 2021-02-18 2021-02-18 0001371128 NEWH:EmployeeMember 2021-02-18 0001371128 2021-09-29 0001371128 NEWH:EmployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-02-18 2021-02-18 0001371128 NEWH:EmployeeMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-02-18 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentTwentyFourMonthsMember 2021-02-18 2021-02-18 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentTwentyFourMonthsMember 2021-03-18 2021-03-18 0001371128 NEWH:EmployeeMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-03-18 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentThirtySixMonthsMember 2021-03-18 2021-03-18 0001371128 NEWH:EmployeeMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-04-12 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentTwentyFourMonthsMember 2022-04-11 2022-04-12 0001371128 2022-03-01 0001371128 2022-02-28 2022-03-01 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentThirtySixMonthsMember 2022-03-15 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentThirtySixMonthsMember 2022-03-14 2022-03-15 0001371128 NEWH:EmployeeMember 2022-04-11 2022-04-12 0001371128 NEWH:EmployeeMember 2022-04-12 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentTenMonthsMember 2022-04-11 2022-04-12 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentTenMonthsMember 2022-04-12 0001371128 NEWH:EmployeeMember NEWH:FirstInstallmentTwentyTwoMonthsMember 2022-04-11 2022-04-12 0001371128 2022-01-01 2022-03-31 0001371128 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001371128 us-gaap:ComputerEquipmentMember 2022-01-01 2022-06-30 0001371128 us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-06-30 0001371128 us-gaap:SeriesCPreferredStockMember 2022-01-01 2022-06-30 0001371128 us-gaap:SeriesCPreferredStockMember 2022-06-30 0001371128 us-gaap:SeriesBPreferredStockMember 2021-01-13 2021-01-14 0001371128 us-gaap:SeriesCPreferredStockMember 2021-03-25 2021-03-26 0001371128 2021-03-25 2021-03-26 0001371128 us-gaap:SeriesCPreferredStockMember 2021-03-26 0001371128 us-gaap:SeriesCPreferredStockMember us-gaap:MeasurementInputPriceVolatilityMember 2021-03-26 0001371128 us-gaap:SeriesCPreferredStockMember us-gaap:MeasurementInputExpectedTermMember 2021-03-26 0001371128 us-gaap:ConvertibleDebtMember 2021-01-01 2021-06-30 0001371128 us-gaap:InvestorMember NEWH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-06-30 0001371128 srt:MaximumMember us-gaap:InvestorMember us-gaap:CommonStockMember NEWH:SecuritiesPurchaseAgreementMember 2021-01-01 2021-06-30 0001371128 srt:MaximumMember us-gaap:InvestorMember us-gaap:WarrantMember NEWH:SecuritiesPurchaseAgreementMember 2021-06-30 0001371128 us-gaap:InvestorMember us-gaap:CommonStockMember NEWH:SecuritiesPurchaseAgreementMember 2021-06-30 0001371128 us-gaap:InvestorMember NEWH:SecuritiesPurchaseAgreementOneMember 2021-01-01 2021-06-30 0001371128 srt:MaximumMember us-gaap:InvestorMember us-gaap:CommonStockMember NEWH:SecuritiesPurchaseAgreementOneMember 2021-01-01 2021-06-30 0001371128 srt:MaximumMember us-gaap:InvestorMember us-gaap:WarrantMember NEWH:SecuritiesPurchaseAgreementOneMember 2021-01-01 2021-06-30 0001371128 us-gaap:InvestorMember NEWH:SecuritiesPurchaseAgreementOneMember 2021-06-30 0001371128 NEWH:ConvertiblePromissoryNotesMember 2021-01-01 2021-06-30 0001371128 srt:MinimumMember NEWH:ConvertiblePromissoryNotesMember 2021-06-30 0001371128 srt:MaximumMember NEWH:ConvertiblePromissoryNotesMember 2021-06-30 0001371128 NEWH:ConvertiblePromissoryNotesTwoMember 2021-01-01 2021-06-30 0001371128 NEWH:ConvertiblePromissoryNotesTwoMember 2021-06-30 0001371128 srt:MinimumMember NEWH:ConvertiblePromissoryNotesTwoMember 2021-06-30 0001371128 srt:MaximumMember NEWH:ConvertiblePromissoryNotesTwoMember 2021-06-30 0001371128 2021-03-26 0001371128 us-gaap:OptionMember 2022-01-01 2022-06-30 0001371128 NEWH:ExercisablePricesOneMember 2022-06-30 0001371128 NEWH:ExercisablePricesOneMember 2022-01-01 2022-06-30 0001371128 NEWH:ExercisablePricesTwoMember 2022-06-30 0001371128 NEWH:ExercisablePricesTwoMember 2022-01-01 2022-06-30 0001371128 NEWH:ExercisablePricesThreeMember 2022-06-30 0001371128 NEWH:ExercisablePricesThreeMember 2022-01-01 2022-06-30 0001371128 NEWH:WarrantOneMember 2022-06-30 0001371128 NEWH:WarrantTwoMember 2022-06-30 0001371128 NEWH:WarrantThreeMember 2022-06-30 0001371128 NEWH:WarrantFourMember 2022-06-30 0001371128 NEWH:WarrantFiveMember 2022-06-30 0001371128 2022-03-14 2022-03-15 0001371128 2022-03-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM __________ TO __________

 

COMMISSION FILE NUMBER: 000-54819

 

NEWHYDROGEN, INC.

(Name of registrant in its charter)

 

Nevada   20-4754291

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

27936 Lost Canyon Road, Suite 202, Santa Clarita, CA 91387

(Address of principal executive offices) (Zip Code)

 

Issuer’s telephone Number: (661) 251-0001

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

The number of shares of registrant’s common stock issued and outstanding as of August 9, 2022 was 715,496,051.

 

 

 

 

 

 

NEWHYDROGEN, INC.

 

INDEX

 

    Page
PART I: FINANCIAL INFORMATION  
     
ITEM 1 FINANCIAL STATEMENTS (Unaudited) 1
  Condensed Balance Sheets 1
  Condensed Statements of Operations 2
  Condensed Statement of Shareholders’ Deficit 3
  Condensed Statements of Cash Flows 4
  Notes to the Condensed Financial Statements 5
ITEM 2 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 11
ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 14
ITEM 4 CONTROLS AND PROCEDURES 14
     
PART II: OTHER INFORMATION  
     
ITEM 1 LEGAL PROCEEDINGS 15
ITEM 1A RISK FACTORS 15
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 15
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 15
ITEM 4 MINE SAFETY DISCLOSURES 15
ITEM 5 OTHER INFORMATION 15
ITEM 6 EXHIBITS 15
     
SIGNATURES 16

 

i

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NEWHYDROGEN, INC.

CONDENSED BALANCE SHEET

 

                 
    June 30, 2022     December 31, 2021  
    (Unaudited)        
ASSETS                
                 
CURRENT ASSETS                
Cash   $ 5,780,563     $ 6,645,710  
Prepaid expenses     39,861       12,023  
                 
TOTAL CURRENT ASSETS     5,820,424       6,657,733  
                 
PROPERTY AND EQUIPMENT                
Machinery and equipment     37,225       37,225  
Less accumulated depreciation     (34,016 )     (33,366 )
                 
NET PROPERTY AND EQUIPMENT     3,209       3,859  
                 
OTHER ASSETS                
Patents, net of amortization of $19,645  and $18,134, respectively     25,691       27,202  
Deposit     770       770  
                 
TOTAL OTHER ASSETS     26,461       27,972  
                 
TOTAL ASSETS   $ 5,850,094     $ 6,689,564  
                 
LIABILITIES AND SHAREHOLDERS’ DEFICIT                
                 
CURRENT LIABILITIES                
Accounts payable   $ 1     $ 1,780  
                 
TOTAL CURRENT LIABILITIES     1       1,780  
                 
COMMITMENTS AND CONTINGENCIES (See Note 9)     -       -  
                 
Series C Convertible Preferred Stock, 34,853 and 34,853 shares outstanding, respectively, redeemable value of $3,485,313 and $3,485,313, respectively     3,485,313       3,485,313  
                 
SHAREHOLDERS’ EQUITY                
Preferred stock, $0.0001 par value; 10,000,000 authorized shares     -       -  
Common stock, $0.0001 par value; 3,000,000,000 authorized shares 715,496,051 and 715,496,051 shares issued and outstanding, respectively     71,549       71,549  
Preferred treasury stock, 0 and 1,000 shares outstanding, respectively     -       -  
Additional paid in capital     169,424,478       164,000,447  
Accumulated deficit     (167,131,247 )     (160,869,525 )
                 
TOTAL SHAREHOLDERS’ EQUITY     2,364,780       3,202,471  
                 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   $ 5,850,094     $ 6,689,564  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

1

 

 

NEWHYDROGEN, INC.

CONDENSED STATEMENTS OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021

(Unaudited)

 

      1       2       3       4  
    Three Months Ended     Six Months Ended  
    June 30, 2022     June 30, 2021     June 30, 2022     June 30, 2021  
                         
REVENUE   $ -     $ -     $ -     $ -  
                                 
OPERATING EXPENSES                                
General and administrative expenses     3,229,645       3,637,312       5,809,704       18,438,830  
Research and development     230,546       251,776       451,092       508,440  
Depreciation and amortization     1,070       1,091       2,161       2,182  
                                 
TOTAL OPERATING EXPENSES     3,461,261       3,890,179       6,262,957       18,949,452  
                                 
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES)     (3,436,261 )     (3,890,179 )     (6,262,957 )     (18,949,452 )
                                 
OTHER INCOME/(EXPENSES)                                
Interest income     601       919       1,235       1,285  
Gain on settlement of debt and derivatives     -       -       -       96,666,293  
Gain (Loss) on change in derivative liability     -       250,293       -       (30,039,479 )
Interest expense     -       (15,977 )     -       (563,914 )
                                 
TOTAL OTHER INCOME (EXPENSES)     601       235,235       1,235       66,064,185  
                                 
NET INCOME (LOSS)   $ (3,436,302 )   $ (3,654,944 )   $ (6,261,722 )   $ 47,114,733  
                                 
BASIC EARNINGS (LOSS) PER SHARE   $ (0.01 )   $ (0.01 )   $ (0.01 )   $ 0.18  
                                 
DILUTED EARNING (LOSS) PER SHARE   $ (0.01 )   $ (0.01 )   $ (0.01 )   $ 0.06  
                                 
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING                                
BASIC     715,496,051       659,726,820       715,496,051       267,786,651  
                                 
DILUTED     715,496,051       659,726,820       715,496,051       740,069,136  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

NEWHYDROGEN, INC.

CONDENSED STATEMENT OF SHAREHOLDERS’ DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021

(Unaudited)

 

                                                                 
    SIX MONTHS ENDED JUNE 30, 2021  
                                  Additional              
    Preferred Stock           Common Stock     Paid-in     Accumulated        
    Shares     Amount     Mezzanine     Shares     Amount     Capital     Deficit     Total  
Balance at December 31, 2020     -       -     $ -       456,198,529     $ 45,620     $ 13,114,993       (165,075,501 )     (151,914,888 )
                                                                 
Issuance of common shares for cash     -       -       -       178,333,334       17,833       8,763,868       -       8,781,701  
                                                                 
Issuance of common shares for converted promissory notes and accrued interest     -       -       -       21,964,188       2196       203,779       -       205,975  
                                                                 
Issuance of common shares for services     -       -       -       1,000,000       100       149,700       -       149,800  
                                                                 
Issuance of preferred shares in exchange for fair value of convertible notes     -       -       -       -       -       85,555,201       -       85,555,201  
                                                                 
Issuance of common shares for conversion of preferred stock     -       -       -       28,000,000       2,800       (2,800 )     -       -  
                                                                 
Issuance of Series C Preferred stock     -       -       3,485,313       -       -       -       -       -  
                                                                 
Stock compensation cost     -       -       -       -       -       17,813,834       -       17,813,834  
                                                                 
Issuance of common stock warrants deemed dividends     -       -       -       -       -       5,983,504       (5,983,504 )     -  
                                                                 
Net Loss     -       -       -       -       -       -       47,114,733       47,114,733  
                                                                 
Balance at June 30 201 (unaudited)     -       -     $ 3,485,313       685,496,051     $ 68,549     $ 131,582,079     $ (123,944,272 )   $ 7,706,356  

 

    SIX MONTHS ENDED JUNE 30, 2022  
                                  Additional              
    Preferred Stock           Common Stock     Paid-in     Accumulated        
    Shares     Amount     Mezzanine     Shares     Amount     Capital     Deficit     Total  
Balance at December 31, 2021     -     $ -     $ 3,485,313       715,496,051     $ 71,549     $ 164,000,447     $ (160,869,525 )   $ 3,202,471  
                                                                 
Issuance of common stock warrants for cash     -       -       -       -       -       1,000       -       1,000  
                                                                 
Stock and warrant compensation cost     -       -       -       -       -       5,423,031       -       5,423,031  
                                                                 
Rounding     -       -       -       -       -       -       -       -  
                                                                 
Net Loss     -       -       -       -       -       -       (6,261,722 )     (6,261,722 )
                                                                 
Balance at June 30, 2022 (unaudited)     -     $ -     $ 3,485,313       715,496,051     $ 71,549     $ 169,424,478     $ (167,131,247 )   $ 2,364,780  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

NEWHYDROGEN, INC.

CONDENSED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

(Unaudited)

 

      1       2  
    Six Months Ended  
    June 30, 2022     June 30, 2021  
CASH FLOWS FROM OPERATING ACTIVITIES:                
Net Income (Loss)   $ (6,261,722 )   $ 47,114,733  
Adjustment to reconcile net income(loss) to net cash (used in) provided by operating activities                
Depreciation and amortization expense     2,161       2,182  
Common stock issued for services     -       149,800  
Stock compensation expense     5,423,031       17,813,834  
(Gain) Loss on net change in derivative liability     -       30,039,479  
Amortization of debt discount recognized as interest expense     -       449,100  
Gain on settlement of debt and derivative     -       (96,666,293 )
(Increase) Decrease in Changes in Assets                
Prepaid expenses     (27,838 )     (230,772 )
Increase (Decrease) in Changes in Liabilities                
Accounts payable     (1,779 )     530  
Accrued expenses     -       63,033  
                 
NET CASH USED IN OPERATING ACTIVITIES     (866,147 )     (1,264,374 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:     -       -  
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds for the sale of common stock for cash, net     -       8,781,700  
Principle payments on convertible debt     -       (203,000 )
Net proceeds from convertible promissory notes     -       192,000  
Common stock purchase warrants for cash     1,000       -  
                 
NET CASH PROVIDED BY FINANCING ACTIVITIES     1,000       8,770,700  
                 
NET INCREASE IN CASH     (865,147 )     7,506,326  
                 
CASH, BEGINNING OF YEAR     6,645,710       63,496  
                 
CASH, END OF YEAR   $ 5,780,563     $ 7,569,822  
                 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION                
Interest paid   $ -     $ -  
Taxes paid   $ -     $ -  
                 
SUPPLEMENTAL SCHEDULE OF NON-CASH TRANSACTIONS                
Common stock issued for convertible notes and accrued interest   $ -     $ 205,975  
Fair value of initial derivative   $ -     $ 180,004  
Fair value of convertible notes exchanged for preferred stock   $ -     $ 85,555,201  

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

NEWHYDROGEN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS – UNAUDITED

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

 

1. Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2022, are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. For further information refer to the financial statements and footnotes thereto included in the Company’s Form 10-K for the December 31, 2021.

 

Going Concern Substantial Doubt Alleviated

 

As of the six months ended June 30, 2022, the Company had a net loss of $6,261,722. As of June 30, 2022, its shareholders equity was $2,364,780.

 

Management believes the Company’s present cash flows will enable it to meet its obligations for twenty-four months from the date of these financial statements. Management will continue to assess it operational needs and seek additional financing as needed to fund its operations..

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

 

Revenue Recognition

 

The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. The Company adopted Accounting Standards Codification (“ASC”) 606, whereby revenue will be recognized as performance obligations are satisfied and customers obtain control of goods or services. However, in the event of a loss on a sale is foreseen, the Company will recognize the loss as it is determined. To date, the Company has not had significant revenues and is in the development stage.

 

Cash and Cash Equivalent

 

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.

 

Concentration Risk

 

Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of June 30, 2022, the cash balance in excess of the FDIC limits was $5,477,784. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements, include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates.

 

Property and Equipment

 

Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives:

 

Computer equipment     5 Years  
Machinery and equipment     10 Years  

 

Depreciation expense for the six months ended June 30, 2022 and 2021 was $2,161 and $2,182, respectively.

 

5

 

 

NEWHYDROGEN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS – UNAUDITED

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Intangible Assets

 

The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives.

  

    Useful Lives   6/30/ 2022     12/31/2021  
Patents       $ 45,336     $ 45,336  
Less accumulated amortization   15 years     (19,645 )     (18,134 )
Intangible assets       $ 25,691     $ 27,202  

 

Amortization expense for the six months ended June 30, 2022 and the year ended December 31, 2021 was $1,511 and $3,022, respectively.

 

Stock-Based Compensation

 

The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period.

 

On March 24, 2015, the Company granted 2,450,000 stock options and on September 2, 2015 granted 13,500,000 stock options to its employees and directors for services. On March 24, 2022, the 2,450,000 options expired leaving the September 2, 2015 options of 13,500,000 outstanding.

 

On February 18, 2021, the Company granted 450,000,000 stock options to its employees for services at an exercise price of $0.091. On September 29, 2021, the Company amended the exercise price to $0.028 per share. The options expire, and all rights to purchase the shares shall terminate seven (7) years from the date of grant or termination of employment. Half of the 400,000,000 options vested immediately upon grant, and the remaining half of the option to purchase 200,000,000 shares of the Company’s common stock shall become exercisable in equal amounts over a twenty-four (24) month period during the term of the optionee’s employment, with the first installment of 8,333,333 shares vesting on March 18, 2021. The 50,000,000 options are exercisable in equal amounts over a thirty-six (36) month period during the term of the optionee’s employment, with the first installment of 1,388,889 shares, vesting on March 18, 2021. On April 12, 2022, the Company cancelled the 450,000,000 stock options dated February 18, 2021, and concurrently granted 450,000,000 new options to its’ employees for services.

 

On March 1, 2022, the Company issued 5,000,000 common stock purchase warrants through a securities purchase agreement for a purchase price of $1,000.

 

On March 15, 2022, the Company granted 5,000,000 stock options to a consultant for advisory services. The options vest at a rate of 138,889 options per month for a thirty-six (36) month period during the term of the optionee’s consultancy with the Company.

 

On April 12, 2022, the Company granted 450,000,000 stock options to its employees for services at an exercise price of $0.021. The options expire, and all rights to purchase the shares shall terminate seven (7) years from the date of grant or termination of employment. The vesting schedule of the 400,000,000 options are exercisable in the amount of 316,666,662 immediately, and the remaining 83,333,338 shares shall become exercisable in equal amounts over a ten (10) month period during the term of the optionee’s employment until the Option is 100% vested. The 50,000,000 options are exercisable in the amount of 19,444,446 immediately and the remaining 30,555,554 shares shall become exercisable in equal amounts over a twenty-two (22) month period during the term of the optionee’s employment until the Options is 100% vested.

 

Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company used Black Scholes to value its stock option awards which incorporated the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. The stock options terminate seven (7) years from the date of grant or upon termination of employment. As of June 30, 2022, the aggregate total of 468,500,000 stock options were outstanding.

 

Research and Development

 

Research and development costs are expensed as incurred. Total research and development costs were $451,092 and $508,440 for the six months ended June 30, 2022 and 2021, respectively.

 

6

 

 

NEWHYDROGEN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS – UNAUDITED

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Net Earnings (Loss) per Share Calculations

 

Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5).  

 

For the six months ended June 30, 2022, the Company has not included shares issuable from 468,500,000 stock options and 228,958,334 warrants, because their impact on the income per share is antidilutive.

 

The Company has included shares issuable from convertible debt of $107,000 and 440,950,000 stock options for the six months ended June 30, 2021, because their impact on the income per share is dilutive.

  

    1     2  
    For the Six Months Ended  
    June 30,  
    2022     2021  
             
Income (Loss) to common shareholders (Numerator)   $ (6,261,722 )   $ 47,114,733  
                 
Basic weighted average number of common shares outstanding (Denominator)     715,496,051       267,786,651  
                 
Diluted weighted average number of common shares outstanding (Denominator)     715,496,051       740,069,136  

 

Fair Value of Financial Instruments

 

Fair Value of Financial Instruments requires disclosure of the fair value information, whether recognized in the balance sheet, where it is practicable to estimate that value. As of June 30, 2022, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities.

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:

 

  Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
     
  Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
     
  Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

We measure certain financial instruments at fair value on a recurring basis. As of June 30, 2022, there were no financial instruments to report.

 

Recently Issued Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

 

Reclassification

 

Certain amounts in the 2021 financial statements have been reclassified to conform to the presentation used in the 2022 financial statements. There was no material impact on any of the Company’s previously issued financial statements.

 

7

 

 

NEWHYDROGEN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS – UNAUDITED

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

 

3. CAPITAL STOCK

 

Preferred Stock June 30, 2022

 

As of June 30, 2022, the Company had a total of 34,853 shares of Series C Preferred Stock outstanding with a fair value of $3,485,313, and a stated face value of one hundred dollars ($100) per share which are convertible into shares of fully paid and non-assessable shares of common stock of the Company. The holder of the Series C preferred stock are entitled to receive dividends pari passu with the holders of common stock, except upon liquidation, dissolution and winding up of the Corporation. The stock was presented as mezzanine equity because it is redeemable at a fixed or determinable amount upon an event that is outside of the issuer’s control. The holder has the right, at any time, at its election, to convert shares of Series C Preferred Stock into common stock at a conversion price of $0.0014 and has no voting rights.

 

Preferred Stock March 31, 2021

 

On January 14, 2021, the Board of Directors adopted a certificate of designation establishing the rights, preferences, privileges and other terms of 1,000 Series B Preferred Stock, par value $0.0001 per share, providing for supermajority voting rights to holders of Series B Preferred Stock. The shares of the Series B Preferred Stock were issued to David Lee, Chief Executive Officer, Chairman of the Board, President and acting Chief Financial Officer as consideration for his continued employment with the Company.

 

On March 26, 2021, the Company entered into a purchase agreement with an investor for an exchange of convertible debt into equity. The investor exchanged convertible notes in the amount of $2,462,060, plus interest in the amount of $1,023,253 for an aggregate total of $3,485,313 in exchange for 34,853 shares of the Company’s Series C Preferred Stock. The extinguishment of the convertible debt and derivative was recognized in the Company’s financial statement as a gain on settlement of convertible notes and derivative liability. A valuation was prepared based on a stock price of $0.075, with a volatility of 206.03%, based on an estimated term of 5 years.

 

Per Valuation      
Preferred shares issued     34,853  
Stated value of debt and interest   $ 3,485,313  
Calculated fair value of preferred shares   $ 85,555,201  
Fair value of derivative liability removed   $ 178,736,187  
Gain   $ (93,180,986 )

 

The Company recognized a gain on settlement of $93,180,986 for the extinguishment of convertible debt, plus derivative liability for the six months ended June 30, 2021.

 

Common Stock June 30, 2022

 

During the six months ended June 30, 2022, the Company issued 5,000,000 common stock purchase warrants for cash in the amount of $1,000.

 

Common Stock June 30, 2021

 

During the six months ended June 30, 2021, the Company issued an aggregate of 52,000,000 shares of common stock and separate pre-funded warrants to purchase up to 31,333,334 shares of common stock, plus warrants to purchase up to 83,333,334 at an exercise price of $0.06 per share.

 

During the six months ended June 30, 2021, the Company issued 65,000,000 shares of common stock and separate pre-funded warrants to purchase up to 60,000,000 shares of common stock, plus warrants to purchase up to 125,000,000 at an exercise price of $0.04 per shares.

 

During the six months ended June 30, 2021, the Company issued 21,964,188 shares of common stock upon conversion of convertible promissory notes in the amount of $184,124, plus accrued interest of $20,851, and other fees of $1,000 at prices ranging from $0.0014 - $0.0641.

 

During the six months ended June 30, 2021, the Company issued 73,273,212 shares of common stock upon conversion of convertible promissory notes in the amount of $587,628, plus accrued interest of $74,006, and other fees of $500 at prices ranging from $0.00495 - $0.0172.

 

During the six months ended June 30, 2021, the Company issued 1,000,000 shares of common stock for services at fair value.

 

8

 

 

NEWHYDROGEN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS – UNAUDITED

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

 

3. CAPITAL STOCK (Continued)

 

Common Stock June 30, 2021 (Continued)

 

During the six months ended June 30, 2021, the Company issued 28,000,000 shares of common stock upon conversion of 392 shares of preferred stock.

 

 

4. STOCK OPTIONS AND WARRANTS

 

Stock Options

 

During the six months ended June 30, 2022, the Company granted stock options in the amount of 5,000,000. (See Note 2).

 

    6/30/2022  
    Number of Options     Weighted average exercise price  
Outstanding as of the beginning of the periods     465,950,000     $ 0.0385  
Granted     455,000,000     $ 0.0210  
Exercised     -       -  
Expired/Cancelled     (452,450,000 )   $ 0.0283  
Outstanding as of the end of the periods     468,500,000     $ 0.0279  
Exercisable as of the end of the periods     376,265,187     $ 0.0296  

 

The weighted average remaining contractual life of options outstanding as of June 30, 2022 was as follows:

 

6/30/2022        
Exercisable Price     Stock Options Outstanding    

Stock Options

Exercisable

    Weighted Average Remaining Contractual Life (years)  
$ 0.26       13,500,000       13,500,000       0.18  
$ 0.0223       5,000,000       488,584       2.71  
$ 0.021       450,000,000       362,276,603       6.79  
          468,500,000       376,265,187          

 

The stock-based compensation expense recognized in the statement of operations during the six months ended June 30, 2022 related to these options was $5,423,031.

 

As of June 30, 2022, there was no intrinsic value with regards to the outstanding options.

 

Warrants

 

During the period ended June 30, 2022, the Company issued 5,000,000 common stock purchase warrants through a securities purchase agreement for a purchase price of $1,000.

    6/30/2022  
   

Number of

Warrants

    Weighted average exercise price  
Outstanding as of the beginning of the periods     223,958,334     $ 0.0488  
Issued     -       -  
Purchased     5,000,000     $ 0.0255  
Expired     -       -  
Outstanding as of the end of the periods     228,958,334     $ 0.0483  
Exercisable as of the end of the periods     228,958,334     $ 0.0483  

 

9

 

 

NEWHYDROGEN, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS – UNAUDITED

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2021

 

4. STOCK OPTIONS AND WARRANTS (Continued)

 

The weighted average remaining contractual life of the warrants outstanding as of June 30, 2022 was as follows:

 

6/30/2022  
Exercisable Price     Stock Warrants Outstanding     Stock Warrants Exercisable     Weighted Average Remaining Contractual Life (years)  
$ 0.0255       5,000,000       5,000,000       4.71  
$ 0.04       125,000,000       125,000,000       3.77  
$ 0.05       9,375,000       9,375,000       3.76  
$ 0.06       83,333,334       83,333,334       4.08  
$ 0.075       6,250,000       6,250,000       4.08  
          228,958,334       228,958,334          

 

During the period, the Company recognized warrant compensation at fair value in the amount $115,102.

 

5. COMMITMENTS AND CONTINGENCIES

 

The Company rents office space on a yearly basis with a monthly rent payment in the amount of $550.

 

In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position or results of operations.

 

On March 15, 2022, the Company entered into an advisor agreement for services regarding various aspects of the Company’s business, including but not limited to technology, business development, and product development. The Company granted 5,000,000 common stock options, vesting at a rate of 138,889 options per month for thirty-six (36) months of consecutive service to the Company, as well as cash compensation of $5,000 per month for the services provided.

 

As of June 30, 2022, there were no legal proceedings against the Company.

 

6. SUBSEQUENT EVENT

 

Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has reported no subsequent events.

 

10

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Special Note on Forward-Looking Statements.

 

Certain statements in “Management’s Discussion and Analysis and Results of Operations” below, and elsewhere in this quarterly report, are not related to historical results, and are forward-looking statements. Forward-looking statements present our expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements frequently are accompanied by such words such as “may,” “will,” “should,” “could,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” or the negative of such terms or other words and terms of similar meaning. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements, or timeliness of such results. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such forward-looking statements. We are under no duty to update any of the forward-looking statements after the date of this quarterly report. Subsequent written and oral forward looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety by the cautionary statements and risk factors set forth in our annual report on Form 10-K filed with the SEC on June 30, 2022, and in other reports filed by us with the SEC.

 

You should read the following description of our financial condition and results of operations in conjunction with the financial statements and accompanying notes included in this report.

 

Overview

 

We are a developer of Green Hydrogen technologies. Our current focus is on developing an electrolyzer technology to lower the cost of Green Hydrogen production. Green Hydrogen is the term used to refer to Hydrogen fuel that is created using renewable energy instead of fossil fuels.

 

Hydrogen is the cleanest and most abundant fuel in the universe. It is zero-emission and only produces water vapor when used. However, hydrogen does not exist in its pure form on Earth so it must be extracted. For centuries, scientists have known how to utilize electricity to split water into hydrogen and oxygen using a device called an electrolyzer. Electrolyzers installed behind a solar farm or wind farm can use renewable electricity to split water, thereby producing Green Hydrogen. However, modern electrolyzers still cost too much. The chemical catalysts that enable the water-splitting reactions are currently made from platinum and iridium – both are very expensive precious metals. These catalysts account for nearly 50% of the cost of the electrolyzer.

 

We are developing technologies to significantly reduce or replace rare earth materials with inexpensive earth abundant materials in electrolyzers to help usher in a Green Hydrogen economy.

 

As of April 30, 2021, we changed our name from BioSolar, Inc. to NewHydrogen, Inc.

 

Recent Transactions

 

None.

 

11

 

 

Application of Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to impairment of property, plant and equipment, intangible assets, deferred tax assets and fair value computation using a Binomial lattice valuation model. We base our estimates on historical experience and on various other assumptions, such as the trading value of our common stock and estimated future undiscounted cash flows, that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions; however, we believe that our estimates, including those for the above-described items, are reasonable.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements, include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates.

 

Fair Value of Financial Instruments

 

Our cash, cash equivalents, investments, inventory, prepaid expenses, and accounts payable are stated at cost which approximates fair value due to the short-term nature of these instruments.

 

Recently Issued Accounting Pronouncements

 

Management reviewed currently issued pronouncements during the three months ended June 30, 2022, and does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed unaudited financial statements.

 

Results of Operations – Three Months Ended June 30, 2022 Compared to the Three Months Ended June 30, 2021.

 

OPERATING EXPENSES

 

General and Administrative Expenses

 

General and administrative (“G&A”) expenses increased by $407,667 to $3,229,645 for the three months ended June 30, 2022, compared to $3,637,312 for the prior period ended June 30, 2021. The primary increase in G&A expenses was the result of an decrease in fair value of non-cash stock compensation of $407,702, an increase in professional fees in the amount of $4,026, with an overall decrease in G&A expenses of $3,991.

 

Research and Development

 

Research and Development (“R&D”) expenses decreased by $21,230 to $230,546 for the three months ended June 30, 2022, compared to $251,776 for the prior period ended June 30, 2021. This overall decrease in R&D expenses was the result of a decrease in outside research fees.

 

Depreciation

 

Depreciation expense for the three months ended June 30, 2022 and 2021 was $1,070 and $1,091, respectively.

 

Other Income/(Expenses)

 

Other income and (expenses) decreased by $234,634 to $601 for the three months ended June 30, 2022, compared to $235,235 for the prior period ended June 30, 2021. The decrease in other income and (expenses) was the result of a decrease in gain of non-cash accounts associated with the change in fair value of the derivative instruments of $250,293, a decrease in interest expense of $15,977, which includes non-cash expense of amortization of debt discount in the amount of $13,338, with a decrease in interest income of $318. The decrease in other income and (expenses) was primarily due to the net change in the fair value of the derivative instruments.

 

12

 

 

Net Income (Loss)

 

Our net loss for the three months ended June 30, 2022 was $(3,460,660), compared to $(3,654,944) for the prior period ended June 30, 2021. The increase in net loss was due to an increase in non-cash other income associated with the net change in derivative instruments estimated in the current period. These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities fluctuate from period to period, and the fluctuation may be material. The Company has not generated any revenues.

 

Results of Operations – Six Months Ended June 30, 2022 Compared to the Six Months Ended June 30, 2021.

 

OPERATING EXPENSES

 

General and Administrative Expenses

 

G&A expenses decreased by $12,629,126 to $5,809,704 for the six months ended June 30, 2022, compared to $18,438,830 for the prior period ended June 30, 2021. The primary decrease in G&A expenses was the result of a decrease in fair value of non-cash stock compensation of $12,390,803, a decrease in professional fees in the amount of $263,558, with an overall increase in G&A expenses of $25,235.

 

Research and Development

 

R&D expenses decreased by $57,348 to $451,092 for the six months ended June 30, 2022, compared to $508,440 for the prior period ended June 30, 2021. This overall decrease in R&D expenses was the result of a decrease in outside research fees.

 

Depreciation

 

Depreciation expense for the six months ended June 30, 2022 and 2021 was $2,161 and $2,182, respectively.

 

Other Income/(Expenses)

 

Other income and (expenses) decreased by $66,062,950 to $1,235 for the six months ended June 30, 2022, compared to $66,064,185 for the prior period ended June 30, 2021. The decrease in other income and (expenses) was the result of a decrease in gain of non-cash accounts associated with the change in fair value of the derivative instruments of $66,626,814, a decrease in interest expense of $563,914, which includes non-cash expense of amortization of debt discount in the amount of $449,100, with a decrease in interest income of $50. The decrease in other income and (expenses) was primarily due to the net change in the fair value of the derivative instruments.

 

Net Income (Loss)

 

Our net loss for the six months ended June 30, 2022 was $(6,261,722), compared to net income of $47,114,733 for the prior period ended June 30, 2021. The decrease in net loss was due to a decrease in non-cash other expenses associated with the net change in derivative instruments estimated in the current period. These estimates were based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, variable conversion prices based on market prices as defined in the respective agreements and probabilities of certain outcomes based on management projections. These inputs were subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liabilities fluctuate from period to period, and the fluctuation may be material. The Company has not generated any revenues.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Liquidity is the ability of a company to generate funds to support its current and future operations, satisfy its obligations, and otherwise operate on an ongoing basis. Significant factors in the management of liquidity are funds generated by operations, levels of accounts receivable and accounts payable and capital expenditures.

 

The unaudited condensed financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying unaudited condensed financial statements do not reflect any adjustments that might result if we are unable to continue as a going concern. During the six months ended June 30, 2022, we did not generate any revenues, and recognized a net loss of $(6,261,722), due to a change in non-cash stock compensation, and cash of $866,147 used in operations. As of June 30, 2022, we had working capital of $6,035,970 and a shareholders’ equity of $2,364,780.

 

Management believes that we will be able to continue to raise funds through the sale of our securities to existing and new investors. Management believes that funding from existing and prospective new investors and future revenue will provide the additional cash needed to meet our obligations as they become due and will allow the development of our core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing.

 

As of June 30, 2022, we had working capital of $5,820,423 compared to $6,655,953 for the year ended December 31, 2021. This decrease in working capital was due primarily to a decrease in cash.

 

During the six months ended June 30, 2022, we used $866,147 of cash for operating activities, as compared to $1,264,374 for the prior six months period ended June 30, 2021. The decrease in the use of cash for operating activities for the current period was a result of a decrease in professional fees and research and development cost.

 

Net cash provided from equity financing activities was $1,000 for the six months ended June 30, 2022, as compared to $8,770,700 for the prior period ended June 30, 2021. The decrease was due to less equity financing during the current period. Our capital needs have primarily been met from the proceeds of the sale of our securities, as we currently have not generated any revenues.

 

Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2021, expressed substantial doubt about our ability to continue as a going concern. Our financial statements as of June 30, 2022 have been prepared under the assumption that we will continue as a going concern. Our ability to continue as a going concern ultimately is dependent upon our ability to generate revenue, which is dependent upon our ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to achieve profitable operations. Our financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

13

 

 

PLAN OF OPERATION AND FINANCING NEEDS

 

We are engaged in the development of innovative technologies to significantly reduce or replace catalysts made from rare earth materials with catalysts made from inexpensive earth abundant materials in electrolyzers to lower the cost of producing Green Hydrogen.

 

Our plan of operation within the next three months is to utilize our cash balances to work on developing catalyst technologies for producing Green Hydrogen. We believe that our current cash and investment balances will be sufficient to support development activity and general and administrative expenses for the next twenty-four months. Management estimates that it will require additional cash resources during 2024, based upon its current operating plan and condition. We do expect increased expenses during the third quarter of 2022. There is no assurance that capital in any form would be available to us, and if available, on terms and conditions that are acceptable. If we are unable to obtain sufficient funds during the next twenty-four months, we may be forced to reduce the size of our organization, which could have a material adverse impact on, or cause us to curtail and/or cease the development of our products

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, as that term is defined in Item 10(f)(1) of Regulation S-K, we are not required to provide information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and acting chief financial officer of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, our chief executive officer and chief financial officer concluded as of June 30, 2022, that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and (ii) accumulated and communicated to our management, including our chief executive officer and acting chief financial officer, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There was no change to our internal control over financial reporting that occurred during our first fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

14

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

As of the date of this report, we are not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

ITEM 1A. RISK FACTORS

 

There are no material changes from the risk factors previously disclosed in the Registrant’s annual report on Form 10-K filed on March 31, 2022.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description
31.1   Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to Sarbanes-Oxley Section 302 (filed herewith).
32.1   Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (filed herewith).
EX-101.INS   Inline XBRL Instance Document
EX-101.SCH   Inline XBRL Taxonomy Extension Schema Document
EX-101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase
EX-101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase
EX-101.LAB   Inline XBRL Taxonomy Extension Labels Linkbase
EX-101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

15

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Angeles, State of California, on August 10, 2022.

 

  NEWHYDROGEN, INC.
   
  By: /s/ David Lee
   

Chief Executive Officer

(Principal Executive Officer) and

Acting Chief Financial Officer

(Principal Financial Officer and

Principal Accounting Officer)

 

16
NewHydrogen (PK) (USOTC:NEWH)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more NewHydrogen (PK) Charts.
NewHydrogen (PK) (USOTC:NEWH)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more NewHydrogen (PK) Charts.